Clinical Trials Browser

Phase 1/2 × INDUSTRY × apalutamide × Clear all

NCT05367440 2026-06-01

PETRANHA

Phase 1/2 Active not recruiting

Prostatic Neoplasms

NCT01171898 2026-05-11

Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)

Phase 1/2 Completed

127 enrolled 16 charts

Prostatic Neoplasms